M-BETAHISTINE
Identification of M-Betahistine
No description |
Google image searchProduct monograph
Active ingredient
betahistine hydrochloride, 8 MG
DIN: 02519682
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: MANTRA PHARMA INC
Date: 27-JUL-2022
ATC:
- N07 — OTHER NERVOUS SYSTEM DRUGS (ATC, ATC/DDD, )
- N07C — ANTIVERTIGO PREPARATIONS (ATC, ATC/DDD)
- N07CA — Antivertigo preparations (ATC, ATC/DDD)
- N07CA01 — BETAHISTINE (ATC/DDD)
Reference brand drug: Serc
Pharmaceutical standard: BP